CEACAM5 and adenocarcinoma: In the whole group, most patients were White (26,839; 78%) and older than 60 years (23,830; 69.2%), had the adenocarcinoma histological type (31,239; 90.7%), moderately differentiated tumors (25,438; 73.9%), LNH ≥ 12 (30,870; 89.7%), and LODDS stage 1 (21,981; 63.8%) and were CEA negative (22,289; 64.7%) and tumor deposit negative (32,106; 93.2%).